A pilot study of N N dimethyltryptamine
Latest Information Update: 20 Nov 2022
At a glance
- Drugs N-N-dimethyltryptamine (Primary)
- Indications Smoking withdrawal
- Focus Adverse reactions
Most Recent Events
- 20 Nov 2022 New trial record
- 10 Nov 2022 According to a Cybin media release, based on the acquisition of the CYB004-E Phase 1 trial replaced this study that was expected to commence in the third quarter of 2022.